Different definitions of sarcopenia and mortality in cancer: A meta-analysis
The DOI matches its Crossref record; 5 of the 5 references it cites were found in a registry or an index.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“The point estimates fall within the range of pooled hazard ratios from recent CRC meta-analyses [7,8,9,10,33]”
In the citing paper
“muscle strength and physical function were not assessed [5,33]”
In the citing paper
“the sarcopenia definition relied on sex-specific SMI thresholds that, while widely used, are not universally standardized”
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Studenski, S. A., Peters, K. W., Alley, D. E., Cawthon, P. M., McLean, R. R., Harris, T. B., Ferrucci, L., Guralnik, J. M., Fragala, M. S., Kenny, A. M., et al. (2014) · The Journals of Gerontology: Series A · doi:10.1093/gerona/glu010 · Cited by 2,545 · cited 1×
“Therefore, it is important to derive cancer type-specific cutoff values by pooling individual cohort data, like the FNIH sarcopenia project which pooled several large population cohorts in deriving cutoff values for sarcopenia in a geriatric population [20].”
BackgroundMitsiopoulos, N., Baumgartner, R. N., Heymsfield, S. B., Lyons, W., Gallagher, D., & Ross, R. (1998) · Journal of Applied Physiology · doi:10.1152/jappl.1998.85.1.115 · Cited by 1,522 · cited 1×
“In CT, L3 skeletal muscle surface measurement at the abdomen is recommended [10,12].”
BackgroundHow Useful Is Body Mass Index for Comparison of Body Fatness across Age, Sex, and Ethnic Groups?
Gallagher, D., Visser, M., Sepulveda, D., Pierson, R. N., Harris, T., & Heymsfield, S. B. (1996) · American Journal of Epidemiology · doi:10.1093/oxfordjournals.aje.a008733 · Cited by 1,513 · cited 1×
“However, it is worth noting that the Martin definition, which stratifies lean mass cutoff according to BMI, may introduce bias since BMI does not distinguish between lean mass and fat mass, which carry different implications in cancer prognosis [16,18].”
BackgroundLee, D. H., Keum, N., Hu, F. B., Orav, E. J., Rimm, E. B., Willett, W. C., & Giovannucci, E. L. (2018) · BMJ · doi:10.1136/bmj.k2575 · Cited by 486 · cited 2×
“However, it is worth noting that the Martin definition, which stratifies lean mass cutoff according to BMI, may introduce bias since BMI does not distinguish between lean mass and fat mass, which carry different implications in cancer prognosis [16,18].”
BackgroundReasons or excuses for avoiding meta-analysis in forest plots
Ioannidis, J. P. A., Patsopoulos, N. A., & Rothstein, H. R. (2008) · BMJ · doi:10.1136/bmj.a117 · Cited by 457 · cited 1×
“To acknowledge the possibility of heterogeneity, the more conservative random effects model was used [24].”
Method
Research works printed but not linked: 18
- van Vugt, 2017, Low skeletal muscle mass is associated with increased hospital expenditure in patients undergoing cancer surgery of the alimentary tract, PLoS One, 12, 10.1371/journal.pone.0186547 · DOI · Paper page
- Arthur, 2016, Cachexia among US cancer patients, J Med Econ, 19, 874
- Fearon, 2011, Definition and classification of cancer cachexia: an international consensus, Lancet Oncol, 12, 489, 10.1016/S1470-2045(10)70218-7 · DOI · Paper page
- Hilmi, 2019, Body composition and sarcopenia: the next-generation of personalized oncology and pharmacology?, Pharmacol Ther, 196, 135, 10.1016/j.pharmthera.2018.12.003 · DOI
- Prado, 2007, Body composition as an independent determinant of 5-fluorouracil-based chemotherapy toxicity, Clin Canc Res, 13, 3264, 10.1158/1078-0432.CCR-06-3067 · DOI · Paper page
- Antoun, 2010, Low body mass index and sarcopenia associated with dose-limiting toxicity of sorafenib in patients with renal cell carcinoma, Ann Oncol, 21, 1594, 10.1093/annonc/mdp605 · DOI · Paper page
- Zhou, 2010, Reversal of cancer cachexia and muscle wasting by ActRIIB antagonism leads to prolonged survival, Cell, 142, 531, 10.1016/j.cell.2010.07.011 · DOI · Paper page
- Advani, 2018, Pharmacological management of cachexia in adult cancer patients: a systematic review of clinical trials, BMC Canc, 18, 1174, 10.1186/s12885-018-5080-4 · DOI
- Cheung, 2021, Systematic review and meta-analysis of lean mass and mortality: Rationale and study description, Osteoporos Sarcopenia, 7, S3, 10.1016/j.afos.2021.01.001 · DOI · Paper page
- Prado, 2008, Prevalence and clinical implications of sarcopenic obesity in patients with solid tumours of the respiratory and gastrointestinal tracts: a population-based study, Lancet Oncol, 9, 629, 10.1016/S1470-2045(08)70153-0 · DOI · Paper page
- Voron, 2015, Sarcopenia impacts on short- and long-term results of hepatectomy for hepatocellular carcinoma, Ann Surg, 261, 1173, 10.1097/SLA.0000000000000743 · DOI · Paper page
- Cesari, 2012, Biomarkers of sarcopenia in clinical trials-recommendations from the international working group on sarcopenia, J Cachexia Sarcopenia Muscle, 3, 181, 10.1007/s13539-012-0078-2 · DOI · Paper page
- Martin, 2013, Cancer cachexia in the age of obesity: skeletal muscle depletion is a powerful prognostic factor, independent of body mass index, J Clin Oncol, 31, 1539, 10.1200/JCO.2012.45.2722 · DOI · Paper page
- Iyengar, 2019, Association of body fat and risk of breast cancer in postmenopausal women with normal body mass index: a secondary analysis of a randomized clinical trial and observational study, JAMA Oncol, 5, 155, 10.1001/jamaoncol.2018.5327 · DOI · Paper page
- Lustgarten, 2011, Assessment of analytical methods used to measure changes in body composition in the elderly and recommendations for their use in phase II clinical trials, J Nutr Health Aging, 15, 368, 10.1007/s12603-011-0049-x · DOI · Paper page
- Hilmi, 2019, Body composition and sarcopenia: the next-generation of personalized oncology and pharmacology?, Pharmacol Ther, 196, 135, 10.1016/j.pharmthera.2018.12.003 · DOI
- von Haehling, 2014, Prevalence, incidence and clinical impact of cachexia: facts and numbers-update 2014, J Cachexia Sarcopenia Muscle, 5, 261, 10.1007/s13539-014-0164-8 · DOI · Paper page
- Go, 2016, Prognostic impact of sarcopenia in patients with diffuse large B-cell lymphoma treated with rituximab plus cyclophosphamide, doxorubicin, vincristine, and prednisone, J Cachexia Sarcopenia Muscle, 7, 567, 10.1002/jcsm.12115 · DOI
Cited by
Wang, D., Sui, J., Chen, J., Chen, L., Yang, Q., Wang, Y., & Lin, S. (2026) · Healthcare · doi:10.3390/healthcare14172846
Metadata
- Authors
- Li, H.-L., Au, P. C.-M., Lee, G. K.-Y., Li, G. H.-Y., Chan, M., Cheung, B. M.-Y., Wong, I. C.-K., Lee, V. H.-F., Mok, J., Yip, B. H.-K., Cheng, K. K.-Y., Wu, C.-H., & Cheung, C.-L.
- ORCID
- Venue
- Osteoporosis and Sarcopenia
- Publisher
- Elsevier BV
- Published
- 2021-03
- Volume
- 7
- Pages
- S34-S38
- ISSN
- 2405-5255
- Cited by
- 26
- References
- 5
- Language
- en
- Licence
- www.elsevier.com/tdm/userlicense/1.0/ (tdm)
- www.elsevier.com/legal/tdmrep-license (tdm)
- creativecommons.org/licenses/by-nc-nd/4.0/ (vor)
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Different definitions of sarcopenia and mortality in cancer: A meta-analysis. https://app.cochat.ai/papers/10.1016/j.afos.2021.02.005
- The paper
- Li, H.-L., Au, P. C.-M., Lee, G. K.-Y., Li, G. H.-Y., Chan, M., Cheung, B. M.-Y., Wong, I. C.-K., Lee, V. H.-F., Mok, J., Yip, B. H.-K., Cheng, K. K.-Y., Wu, C.-H., & Cheung, C.-L. (2021). Different definitions of sarcopenia and mortality in cancer: A meta-analysis. Osteoporosis and Sarcopenia. https://doi.org/10.1016/j.afos.2021.02.005
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.